期刊文献+

磁共振在前列腺特异性抗原低于20μg/L患者中诊断前列腺癌的影像分级研究 被引量:7

The clinical value of magnetic resonance imaging grading for prostate cancer diagnosis in patients with prostate-specific antigen levels less than 20 μg/L
原文传递
导出
摘要 目的 探讨T2加权像(T2WI)和弥散加权像(DWI)的影像分级在前列腺特异性抗原(PSA)<20 μg/L的患者中对前列腺癌诊断的意义. 方法 2011年12月至2013年1月PSA<20μg/L、在我院行前列腺穿刺活检的133例患者.将核磁共振(MRI)上前列腺外周带分为6个分区,评估T2WI和DWI上外周带每个区域的影像级别,以前列腺活检病理结果作为对照,比较两种扫描方式中的分级系统单独或联合应用对于前列腺癌的诊断意义. 结果 60例(45.1%)诊断为前列腺癌.T2WI影像分级中0~5级对应的前列腺癌诊断率分别为2.8%、13.5%、20.4%、34.6%、52.6%和88.9%;T2WI+DWI中1~5级对应的前列腺癌诊断率分别为11.1%、16.1%、48.5%、71.0%和86.1%.随着预先制定的T2WI和T2WI+ DWI影像分级的递增,前列腺活检阳性率增加(Z=-9.8552、-13.4148,均P<0.0001).受试者工作特征曲线分析发现T2WI联合DWI对前列腺癌的诊断能力优于T2WI独立诊断(AUC=0.743与0.715,P=0.0072). 结论 T2WI影像分级标准可以预测PSA<20 μg/L的患者前列腺癌的风险;DWI可以进一步增强对于前列腺癌预测的能力. Objective To explore the clinical value of image gradings of T2 weighted imaging (T2WI) and diffusion weighted imaging (DWI) for prostate cancer diagnosis in patients with prostate specific antigen (PSA) less than 20 μg/L.Methods A total of 133 patients with PSA〈20 μg/L who received prostate biopsies in our hospital from December 2011 to January 2013 were recruited.The prostate was divided into six regions in MRI images.T2WI and DWI image gradings on each region in peripheral zone were evaluated with reference to histopathological evaluation of prostate biopsies.The significance of grading system for the diagnosis of prostate cancer in the two scanning methods alone or in combination were compared.Results 60 patients were diagnosed as prostate cancer.The positive biopsy rates were 2.8%,13.5%,20.4%,34.6%,52.6% and 88.9%,respectively in grade 0-5 based on T2WI imaging grading.The positive biopsy rates were 11.1%,16.1%,48.5%,71.0% and 86.1%,respectively in grade 1-5 based on T2WI+ DWI imaging grading.The positive biopsy rate was significantly increased with the increments of pre-established T2WI and T2WI+DWI image gradings (Z=-9.8552,-13.4148,both P〈0.0001).Receiver operating characteristic analysis showed that the diagnostic capability was better in T2WI combined with DWI than in T2W1 alone in prostate cancer detection (AUC:0.743 vs.0.715,P=0.0072).Conclusions T2WI image grading can predict the risk of prostate cancer in patients with PSA〈20 μg/L,and DWI can enhance the ability to predict prostate cancer.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第5期532-535,共4页 Chinese Journal of Geriatrics
关键词 前列腺肿瘤 磁共振成像 癌症早期检测 Prostatic neoplasms Magnetic resonance imaging Early detection of cancer
  • 相关文献

参考文献8

  • 1Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol, 2011, 59:477-494.
  • 2Kitajima K, Kaji Y, Fukabori Y, et al. Prostate cancer detection with 3 T MRI.. comparison of diffusion-weighted imaging and dynamic contrast- enhanced MRI in combination with T2-weighted imaging. Journal of Magnetic Resonance Imaging, 2010, 31: 625-631.
  • 3陈志强,杨文君,郭玉林,陈福宝,蔡磊,侯登华,张伟,李宁福,赵建国,朱凯.磁共振扩散加权成像在前列腺癌诊断和鉴别诊断中的价值[J].中华老年医学杂志,2011,30(3):216-219. 被引量:13
  • 4Engelhard K, Hollenbach HP, Deimling M, et al. Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer. Eur Radiol, 2000, 10: 1947-1953.
  • 5Schiebler ML, Schnall MD, Pollack HM, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology, 1993,189: 339-352.
  • 6Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol, 2007, 189:323-328.
  • 7Mazaheri Y, Shukla-Dave A, Muellner A, et al. MR imaging of the prostate in clinical practice . Magma, 2008, 21:379-392.
  • 8Rosenkrantz AB, Mannelli L, Kong X, et al. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization. J Magn Reson Imaging, 2011, 34:95-100.

二级参考文献9

  • 1李飞宇,王霄英,许玉峰,肖江喜,蒋学祥.良性前列腺增生的ADC值定量分析[J].实用放射学杂志,2007,23(5):661-664. 被引量:40
  • 2Turner R,Le Bihan D,Maier J, et al. Echo-plannar imaging of intravoxel incoherent motion. Radiology, 1990,177:407 414.
  • 3Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging, 2005,21 : 258-262.
  • 4Hosseinzadeh K,Schwarz SD. Endorectal diffusion - weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging, 2004,20 : 654-661.
  • 5Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging, 2002,16:196-200.
  • 6AtalayB, Kefi A, Nazli O, et al. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens. Urol Int, 2001,67 : 14-18.
  • 7Woodfield CA, Tung GA,Grand DJ, et al. Diffusion weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR, 2010, 194: 316-322.
  • 8郭雪梅,王霄英,李飞宇,蒋学祥.3.0T MR扩散加权成像对前列腺癌的诊断价值[J].中国医学影像技术,2007,23(8):1205-1207. 被引量:33
  • 9陈志强,郭雪梅,王霄英,李飞宇,郭玉林,蒋学祥.前列腺癌扩散加权成像与Gleason评分的相关性研究[J].中国医学影像技术,2009,25(6):1066-1068. 被引量:16

共引文献12

同被引文献52

  • 1倪新初,沈钧康,陆之安,钱农,周丽娟,杨晓春,王灌忠,张彩元,王水珍,项剑波,潘昌杰,荣伟良,陈建国南京医科大学附属常州市第二人民医院泌尿外科,单玉喜,钱铭辉.前列腺癌与良性前列腺增生症的MR动态增强与血管生成的相关性研究[J].中华放射学杂志,2005,39(1):54-59. 被引量:51
  • 2史浩,武乐斌,丁红宇,赵斌,王涛,杨贞振,邱秀玲,李慧华,曲蕾,魏煜龙.MR动态增强、扩散成像和波谱分析在前列腺癌诊断中的价值[J].中华放射学杂志,2006,40(7):678-683. 被引量:37
  • 3那彦群,叶章群,孙光.中国泌尿外科疾病诊断治疗指南.2011版[M].北京:人民卫生出版社,2011.49-53.
  • 4Bonekamp D,Macura KJ. Dynamic contrastenhanced magnetic resonance imaging in the evaluation of the prostate[J].{H}Topics in Magnetic Resonance Imaging,2008.273-284.
  • 5McMahon CJ,Blorh BN,Lenkinski RE,et a1. Dynamic contrast enhanced MR imaging in the evaluation of patients with prostate cancer[J].{H}Magnetic Resonance Imaging Clinics of North America,2009.363-383.
  • 6Engelbrecht MR,Huisman HJ,Laheij RJ,et a1. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast MR imaging[J].{H}RADIOLOGY,2003.248-254.
  • 7Tofts PS,BrixG,Buckley DL,et a1. Estimating kinetic parameters from dynamic contrast T (1)-weighted MRI of a diffusable tracer:standardized quantities and symbols[J].{H}Journal of Magnetic Resonance Imaging,1999.223-232.
  • 8Kozlowski P,Chang SD,Jones EC. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis:correlation with biopsy and histopathology[J].{H}Journal of Magnetic Resonance Imaging,2006.108-113.
  • 9Jackson AS,Reinsberg SA,Sohaib SA. Dynamic contrast enhanced MRI for prostate cancer localization[J].{H}British Journal of Radiology,2009.148-156.
  • 10Schlemmer HP,Merkle J,Grobholz R. Can preoperative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens[J].{H}European Radiology,2004.309-317.

引证文献7

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部